KRISTIN DEUTSCH: Open Payments
NPI 1043215924 · THOMASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,021 in 107 payments from 13 companies in 2025. Trend: 2023 $1,246 · 2024 $1,206 · 2025 $2,021
Food & beverage: $2,021
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $865 |
| Janssen Biotech, Inc. | 13 | $260 |
| Ardelyx, Inc. | 10 | $228 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $186 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $146 |
| PFIZER INC. | 4 | $72 |
| Phathom Pharmaceuticals, Inc. | 4 | $45 |
| Ipsen Biopharmaceuticals, Inc | 2 | $45 |
| EVOKE PHARMA, INC. | 2 | $44 |
| Madrigal Pharmaceuticals | 1 | $43 |
Products named: RINVOQ, TREMFYA, IBSRELA, LINZESS, ENTYVIO, XIFAXAN, CREON, SKYRIZI.
Industry payments across GA — which companies pay providers there.
